Fuente: PubMed "industrial biotechnology" PLoS One. 2025 Dec 16;20(12):e0338330. doi: 10.1371/journal.pone.0338330. eCollection 2025.ABSTRACTBACKGROUND: Epiretinal membrane is a common retinal condition, particularly in the elderly, than can lead to reduced visual acuity and visual distortion. Structural optical coherence tomography biomarkers have shown potential for predicting visual outcomes following surgery.OBJECTIVE: To evaluate the prognostic value of baseline structural optical coherence tomography biomarkers for visual outcomes following epiretinal membrane surgery. We will assess associations between individual biomarkers and postoperative visual acuity or changes in visual acuity at 6, 12, and 24 months after surgery.METHODS: We will systematically search MEDLINE, EMBASE, CENTRAL and Web of Science from inception. Eligible studies will include randomized trials and observational studies reporting the association between any baseline optical coherence tomography biomarkers and postoperative visual acuity in patients undergoing epiretinal membrane surgery. Two reviewers will independently and in duplicate perform screening, data extraction, and risk of bias assessment. Meta-analyses using the restricted maximum likelihood random-effects model will be conducted whenever possible. The certainty of evidence for each estimate will be assessed using the GRADE approach.EXPECTED OUTCOMES: This review will analyze time-specific association between baseline structural optical coherence tomography biomarkers and postoperative visual acuity and change in visual acuity from baseline at 6, 12, and 24 months after surgery, quality of life measured using any validated scale, and adverse events.PMID:41401159 | DOI:10.1371/journal.pone.0338330